# OnCo record isomorphic-labs (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/isomorphic-labs/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "isomorphic-labs" ;
  schema:name "Isomorphic Labs"@en ;
  schema:description "Alphabet's AlphaFold-derived drug design company; its first AI-designed oncology candidate was cleared for human trials in January 2026 after a $2.1B raise."@en ;
  schema:url <https://onco.cc/companies/isomorphic-labs/>, <https://www.isomorphiclabs.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Isomorphic_Labs> ;
  owl:sameAs <http://www.wikidata.org/entity/Q109536010> ;
  schema:citation <https://www.clinicaltrialsarena.com/news/isomorphic-labs-prepares-trials-ai-designed-drugs/> ;
  onco:tag "frontier" ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/ai-computation/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/ai-drug-design/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/>, <https://onco.cc/companies/novartis/> .